Fate Therapeutics
FATE
FATE
157 hedge funds and large institutions have $362M invested in Fate Therapeutics in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 41 increasing their positions, 59 reducing their positions, and 37 closing their positions.
Holders
157
Holders Change
-12
Holders Change %
-7.1%
% of All Funds
2.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
27
Increased
41
Reduced
59
Closed
37
Calls
$101K
Puts
$40K
Net Calls
+$61K
Net Calls Change
+$88K
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$13M |
| 2 |
2
Adage Capital Partners
Boston,
Massachusetts
|
$6.36M |
| 3 |
3
Morgan Stanley
New York
|
$9.88M |
| 4 |
IHAM
4
Integral Health Asset Management
New York
|
$3.37M |
| 5 |
5
Citigroup
New York
|
$3.16M |
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$34.8M |
| 2 |
2
BlackRock
New York
|
$41.9M |
| 3 |
3
Millennium Management
New York
|
$3.34M |
| 4 |
4
D.E. Shaw & Co
New York
|
$13.4M |
| 5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$204K |
